![](/img/cover-not-exists.png)
EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer
John, Thomas, Akamatsu, Hiroaki, Delmonte, Angelo, Su, Wu-Chou, Lee, Jong Seok, Chang, Gee-Chen, Huang, Xiangning, Jenkins, Suzanne, Wu, Yi-LongLanguage:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2018.10.027
Date:
November, 2018
File:
PDF, 354 KB
english, 2018